GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 2cureX AB (OSTO:2CUREX) » Definitions » Enterprise Value

2cureX AB (OSTO:2CUREX) Enterprise Value : kr-11.91 Mil (As of May. 21, 2024)


View and export this data going back to 2017. Start your Free Trial

What is 2cureX AB Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, 2cureX AB's Enterprise Value is kr-11.91 Mil. 2cureX AB's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was kr-31.11 Mil. Therefore, 2cureX AB's EV-to-EBIT ratio for today is 0.38.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, 2cureX AB's Enterprise Value is kr-11.91 Mil. 2cureX AB's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was kr-30.77 Mil. Therefore, 2cureX AB's EV-to-EBITDA ratio for today is 0.39.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, 2cureX AB's Enterprise Value is kr-11.91 Mil. 2cureX AB's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was kr0.25 Mil. Therefore, 2cureX AB's EV-to-Revenue ratio for today is -47.82.


2cureX AB Enterprise Value Historical Data

The historical data trend for 2cureX AB's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

2cureX AB Enterprise Value Chart

2cureX AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Enterprise Value
Get a 7-Day Free Trial 127.15 135.81 187.30 220.65 98.57

2cureX AB Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 118.00 98.57 78.36 46.05 38.93

Competitive Comparison of 2cureX AB's Enterprise Value

For the Biotechnology subindustry, 2cureX AB's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


2cureX AB's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 2cureX AB's Enterprise Value distribution charts can be found below:

* The bar in red indicates where 2cureX AB's Enterprise Value falls into.



2cureX AB Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

2cureX AB's Enterprise Value for the fiscal year that ended in Dec. 2022 is calculated as

2cureX AB's Enterprise Value for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


2cureX AB  (OSTO:2CUREX) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

2cureX AB's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=-11.908/-31.106
=0.38

2cureX AB's current Enterprise Value is kr-11.91 Mil.
2cureX AB's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-31.11 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

2cureX AB's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=-11.908/-30.769
=0.39

2cureX AB's current Enterprise Value is kr-11.91 Mil.
2cureX AB's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-30.77 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

2cureX AB's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=-11.908/0.249
=-47.82

2cureX AB's current Enterprise Value is kr-11.91 Mil.
2cureX AB's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.25 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


2cureX AB Enterprise Value Related Terms

Thank you for viewing the detailed overview of 2cureX AB's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


2cureX AB (OSTO:2CUREX) Business Description

Traded in Other Exchanges
Address
Fruebjergvej 3, Copenhagen, DNK, DK-2100
2cureX AB is a biotech company. The company is engaged in improving treatment efficiency, mainly for cancer patients. It is involved in developing a product, namely IndiTreat, which is a technology for the treatment of colorectal, ovarian, and pancreatic cancers. The company's sub-products include IndiTreat Test, IndiTreat clinical programs, and IndiTreat Therapy Design.

2cureX AB (OSTO:2CUREX) Headlines

No Headlines